The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content.
You can save this article by registering for free here. Or sign-in if you have an account.
Article content
Strong new order inflow and higher backlog¹ entering fiscal 2025
MONTREAL, May 16, 2024 (GLOBE NEWSWIRE) — Velan Inc. (TSX: VLN) (“Velan” or the “Company”), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless indicated otherwise.
Article content
FOURTH QUARTER HIGHLIGHTS:
Bookings1 of $132.8 million, up sharply from $87.1 million last year and $78.3 million in the third quarter.
Book-to-bill1 ratio of 1.13, versus 0.76 for the same period a year ago and 0.97 in the third quarter.
Sales of $117.9 million, up from $115.1 million last year and up from $80.9 million in the third quarter.
Gross profit of $38.4 million, or 32.6% of sales, compared to $39.9 million, or 30.4% of sales, last year.
Net loss2 of $2.1 million compared to a net loss of $47.2 million last year.
Advertisement 2
This advertisement has not loaded yet, but your article continues below.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
Exclusive articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman, Victoria Wells and others.
Daily content from Financial Times, the world’s leading global business publication.
Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
Exclusive articles from Barbara Shecter, Joe O’Connor, Gabriel Friedman, Victoria Wells and others.
Daily content from Financial Times, the world’s leading global business publication.
Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
Access articles from across Canada with one account.
Share your thoughts and join the conversation in the comments.
Enjoy additional articles per month.
Get email updates from your favourite authors.
Sign In or Create an Account
or
Article content
YEAR-END HIGHLIGHTS:
Order backlog1 of $491.5 million, up $27.1 million from last year.
Bookings of $374.5 million, compared to $353.2 million in fiscal 2023.
Book-to-bill ratio of 1.08, versus 0.95 last year.
Sales of $346.8 million, compared to $370.4 million in fiscal 2023.
Gross profit of $93.2 million, or 26.9% of sales, versus $112.5 million, or 30.4% of sales, last year.
Net loss of $19.7 million, versus a net loss of $55.5 million in the prior year.
Cash and cash equivalents of $36.4 million.
FINANCIAL RESULTS (‘000s of U.S. dollars, excluding per share amounts)
Three-month periods ended
Fiscal years ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
Sales
$117,894
$115,141
$346,816
$370,429
Gross profit
$38,384
$39,945
$93,207
$112,465
Gross margin
32.6%
34.7%
26.9%
30.4%
Net loss
($2,083)
($47,164)
($19,737)
($55,453)
per share – basic and diluted
($0.10)
($2.18)
($0.91)
($2.57)
Adjusted EBITDA
$19,879
$16,468
$17,780
$21,092
Adjusted net income (loss)
$8,944
$8,790
($7,918)
$501
per share – basic and diluted
$0.41
$0.41
($0.37)
$0.02
Weighted average share outstanding (‘000s)
21,586
21,586
21,586
21,586
Advertisement 3
This advertisement has not loaded yet, but your article continues below.
Article content
“Velan concluded fiscal 2024 with strong fourth quarter results, marked by heightened sales volume and healthy profit margins on improved quality of execution,” said James A. Mannebach, Chairman and CEO of Velan. “In addition, robust bookings during the period further increased our backlog to $491.5 million at year-end. Given the value of orders to be shipped over the next 12 months, we expect sales growth in fiscal 2025. As a supplier of critical equipment to essential industries, Velan is well positioned to capture growth opportunities driven by the ongoing energy transition and expand its reach in the flow control industry based on an agile workforce, global presence and strong brand recognition.”
“Fueled by a net cash position, Velan’s strong balance sheet will allow the Company to fund its current operations and pursue re-investment to expand its global reach. Over the longer term, we remain committed to building shareholder value through sales and cash flow growth,” added Rishi Sharma, Chief Financial and Administrative Officer of Velan.
BOOKINGS AND BACKLOG (‘000s of U.S. dollars, excluding ratio)
Three-month periods ended
Fiscal years ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
Backlog
$491,525
$464,337
for delivery within the next 12 months
$360,669
$307,991
Bookings
$132,825
$87,085
$374,454
$353,176
Book-to-bill ratio
1.13
0.76
1.08
0.95
Top Stories
Get the latest headlines, breaking news and columns.
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Thanks for signing up!
A welcome email is on its way. If you don’t see it, please check your junk folder.
The next issue of Top Stories will soon be in your inbox.
We encountered an issue signing you up. Please try again
Article content
Advertisement 4
This advertisement has not loaded yet, but your article continues below.
Article content
As at February 29, 2024, the backlog stood at $491.5 million, up $27.2 million, or 5.9%, from $464.3 million a year earlier reflecting strong fourth quarter bookings. As at February 29, 2024, 73.4% of the backlog, representing orders of $360.7 million, is deliverable in the next 12 months, versus 66.3% of last year’s backlog. Currency movements had a positive effect of $5.6 million on the backlog during the year.
Bookings for the fourth quarter of fiscal 2024 amounted to $132.8 million, up 52.5% over bookings of $87.1 million a year earlier. The increase is mainly attributable to strong oil and gas bookings recorded by the Company’s Italian operations and to higher orders recorded by North American operations, partially offset by the timing of orders for the French subsidiary following strong bookings in the prior year. Currency movements had a positive effect of $3.8 million on bookings during the quarter.
As a result of bookings outpacing sales, the Company’s book-to-bill ratio was 1.13 in the fourth quarter of fiscal 2024, compared to 0.76 in the corresponding period of fiscal 2023.
Advertisement 5
This advertisement has not loaded yet, but your article continues below.
Article content
Fiscal 2024 bookings reached $374.5 million, an increase of $21.3 million or 6.0% compared to the previous year. As a result of bookings outpacing sales for the fiscal year, the Company’s book-to-bill ratio was 1.08 in fiscal 2024, compared with 0.95 in fiscal 2023.
FISCAL 2024 FOURTH QUARTER RESULTS
Sales reached $117.9 million, up $2.8 million or 2.4% from last year. The variation is mostly attributable to stronger shipments from the Company’s International operations. These factors were partially offset by lower shipments from North American operations and shipping delays due to the situation in the Red Sea. Currency movements had a $1.7 million positive effect on sales for the quarter.
Gross profit was $38.4 million, versus $39.9 million a year ago. The variation reflects a less favorable product mix this year compared to last due to the execution of certain low margin projects. Last year’s gross profit also benefitted from a favorable revaluation of the inventory provision based on new estimates relating to changes in market demand. As a percentage of sales, gross profit was 32.6%, versus 34.7% last year.
Advertisement 6
This advertisement has not loaded yet, but your article continues below.
Article content
Administration costs reached $33.1 million, compared to $80.8 million last year. This year’s administration costs include a $10.0 million asbestos provision adjustment and restructuring charges of $1.3 million mostly consisting of severances. Last year’s costs included a $56.0 million charge to increase the Company’s asbestos provision. Excluding these items, administration costs totaled $21.7 million, or 18.4% of sales, in the fourth quarter of fiscal 2024, versus $24.9 million, or 21.6% of sales, in the fourth quarter of fiscal 2023. The decrease is mostly due to lower expenses for the North American operations and cost reduction initiatives throughout the Company’s operations.
EBITDA1 reached $8.5 million compared to negative $39.5 million last year. Excluding asbestos and restructuring costs, adjusted EBITDA was $19.9 million in the fourth quarter of fiscal 2024, compared to $16.5 million a year earlier. This increase reflects lower administration costs and a $1.7 million net reduction in other expenses, mainly related to a provision related to a commodity tax audit last year. These factors were partially offset by a lower gross profit.
Advertisement 7
This advertisement has not loaded yet, but your article continues below.
Article content
Net loss was $2.1 million, or $0.10 per share, versus a net loss of $47.2 million, or $2.18 per share last year. Excluding the after-tax effect of asbestos and restructuring costs, adjusted net income was $8.9 million, or $0.41 per share, compared to $8.8 million, or $0.41 per share, last year. The variation is attributable to higher adjusted EBITDA partially offset by higher net finance costs and income tax expense.
YEAR-END RESULTS
For the fiscal year ended February 29, 2024, sales amounted to $346.8 million, down from $370.4 million last year. Gross profit was $93.2 million, or 26.9% of sales, compared to $112.5 million, or 30.4% of sales, last year. EBITDA stood at $5.3 million, versus negative $34.9 million a year ago, while adjusted EBITDA reached $17.8 million compared to $21.1 million last year. Net loss was $19.7 million, or $0.91 per share, compared to a net loss of $55.5 million, or $2.57 per share, a year ago, while adjusted net loss was $7.9 million, or $0.37 per share, compared to adjusted net income of $0.5 million, or $0.02 per share in the prior year.
FINANCIAL POSITION
Advertisement 8
This advertisement has not loaded yet, but your article continues below.
Article content
As at February 29, 2024, Velan’s financial position remained solid. The Company had cash and cash equivalents of $36.4 million, as well as short-term investments of $5.3 million, while long-term debt, including the current portion, amounted to $28.8 million.
OUTLOOK
Velan aims to build on the momentum gained in the second half of fiscal 2024, concluding the year on a solid note with a growing order backlog and a book-to-bill ratio of 1.08. As at February 29, 2024, orders totaling $360.7 million, representing 73.4% of a total backlog of $491.5 million, are expected to be delivered in the next 12 months. Given these orders, the Company expects to deliver annual sales in fiscal 2025 above the level achieved in fiscal 2024.
CONFERENCE CALL NOTICE
Financial analysts, shareholders, and other interested individuals are invited to attend the fourth quarter conference call to be held on Friday, May 17, 2024, at 8:00 a.m. (EDT). The toll-free call-in number is 1-888-660-6345 or 1-289-819-1450. The material that will be referenced during the conference call will be made available shortly before the event on the company’s website under the Investor Relations section (https://www.velan.com/en/company/investor_relations). A recording of this conference call will be available for seven days at 1-289-819-1450 or 1-888-660-6345, access code 24455.
Advertisement 9
This advertisement has not loaded yet, but your article continues below.
Article content
ABOUT VELAN
Founded in Montreal in 1950, Velan Inc. (www.velan.com) is one of the world’s leading manufacturers of industrial valves, with sales of US$346.8 million in its last reported fiscal year. The Company employs approximately 1,641 people and has manufacturing plants in 9 countries. Velan Inc. is a public company with its shares listed on the Toronto Stock Exchange under the symbol VLN.
SAFE HARBOUR STATEMENT
This news release may include forward-looking statements, which generally contain words like “should”, “believe”, “anticipate”, “plan”, “may”, “will”, “expect”, “intend”, “continue” or “estimate” or the negatives of these terms or variations of them or similar expressions, all of which are subject to risks and uncertainties, which are disclosed in the Company’s filings with the appropriate securities commissions. While these statements are based on management’s assumptions regarding historical trends, current conditions and expected future developments, as well as other factors that it believes are reasonable and appropriate in the circumstances, no forward-looking statement can be guaranteed and actual future results may differ materially from those expressed herein. The Company disclaims any intention or obligation to update or revise any forward-looking statements contained herein whether as a result of new information, future events or otherwise, except as required by the applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Advertisement 10
This advertisement has not loaded yet, but your article continues below.
Article content
NON-IFRS AND SUPPLEMENTARY FINANCIAL MEASURES
In this press release, the Company has presented measures of performance or financial condition which are not defined under IFRS (“non-IFRS measures”) and are, therefore, unlikely to be comparable to similar measures presented by other companies. These measures are used by management in assessing the operating results and financial condition of the Company and are reconciled with the performance measures defined under IFRS. The Company has also presented supplementary financial measures which are defined at the end of this report. Reconciliation and definition can be found below.
Adjusted net income, Adjusted net income per share, Earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA
(thousands, except amount per shares)
Three-month period ended
Fiscal years ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
$
$
$
$
Reconciliation of net income (loss) to adjusted net income (loss)2& adjusted net income (loss) per share
Net income (loss)
(2,083
)
(47,164
)
(19,737
)
(55,453
)
Adjustment for:
Proposed transaction related costs
108
–
900
–
Restructuring costs
919
–
919
–
Adjustment to asbestos provision
10,000
55,954
10,000
55,954
Adjusted net income (loss)
8,944
8,790
(7,918
)
501
per share – basic and diluted
0.41
0.41
(0.37
)
0.02
Reconciliation of net income (loss) to Adjusted EBITDA
Net income (loss)
(2,083
)
(47,164
)
(19,737
)
(55,453
)
Adjustments for:
Depreciation of property, plant and equipment
2,472
2,452
8,930
8,722
Amortization of intangible assets and financing costs
650
608
2,296
2,272
Finance costs – net
2,355
516
6,346
1,552
Income taxes
5,088
4,102
7,471
8,045
EBITDA
8,482
(39,486
)
5,306
(34,862
)
Adjustments for:
Proposed transaction related costs
147
–
1,224
–
Restructuring costs
1,250
–
1,250
–
Adjustment to asbestos provision
10,000
55,954
10,000
55,954
Adjusted EBITDA
19,879
16,468
17,780
21,092
Advertisement 11
This advertisement has not loaded yet, but your article continues below.
Article content
The term “Adjusted net income (loss)” is defined as net income or loss attributable to Subordinate and Multiple Voting Shares plus adjustment, net of income taxes, for costs related to the proposed transaction, restructuring, and asbestos provision. The terms “Adjusted net income (loss) per share” is obtained by dividing Adjusted net income (loss) by the total amount of subordinate and multiple voting shares. The forward-looking statements contained in this MD&A are expressly qualified by this cautionary statement.
The term “EBITDA” is defined as adjusted net income plus depreciation of property, plant & equipment, plus amortization of intangible assets, plus net finance costs, plus income tax provision. The term “Adjusted EBITDA” is defined as EBITDA plus adjustment for costs related to the proposed transaction, restructuring, and asbestos provision. The forward-looking statements contained in this MD&A are expressly qualified by this cautionary statement.
Definitions of supplementary financial measures
The term “Net new orders” or “bookings” is defined as firm orders, net of cancellations, recorded by the Company during a period. Bookings are impacted by the fluctuation of foreign exchange rates for a given period. The measure provides an indication of the Company’s sales operation performance for a given period as well as well as an expectation of future sales and cash flows to be achieved on these orders.
Advertisement 12
This advertisement has not loaded yet, but your article continues below.
Article content
The term “backlog” is defined as the buildup of all outstanding bookings to be delivered by the Company. The Company’s backlog is impacted by the fluctuation of foreign exchange rates for a given period. The measure provides an indication of the future operational challenges of the Company as well as an expectation of future sales and cash flows to be achieved on these orders.
The term “book-to-bill” is obtained by dividing bookings by sales. The measure provides an indication of the Company’s performance and outlook for a given period.
The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Contact:
Rishi Sharma, Chief Financial and Administrative Officer
Martin Goulet, M.Sc., CFA
Velan Inc.
MBC Capital Markets Advisors
Tel: (438) 817-4430
Tel.: (514) 731-0000, ext. 229
_______________________ 1 Non-IFRS and supplementary financial measures. Refer to the Non-IFRS and supplementary financial measures section for definitions and reconciliations. 2 Net income or loss refer to net income or loss attributable to Subordinate and Multiple Voting Shares.
Advertisement 13
This advertisement has not loaded yet, but your article continues below.
Article content
Consolidated Statements of Financial Position
(in thousands of U.S. dollars)
As at
February 29,
February 28,
2024
2023
$
$
Assets
Current assets
Cash and cash equivalents
36,445
50,513
Short-term investments
5,271
37
Accounts receivable
119,914
121,053
Income taxes recoverable
6,132
6,195
Inventories
208,702
202,649
Deposits and prepaid expenses
10,421
7,559
Derivative assets
125
107
387,010
388,113
Non-current assets
Property, plant and equipment
69,918
68,205
Intangible assets and goodwill
16,543
16,153
Deferred income taxes
5,193
4,663
Other assets
729
723
92,383
89,744
Total assets
479,393
477,857
Liabilities
Current liabilities
Bank indebtedness
–
260
Accounts payable and accrued liabilities
88,230
79,408
Income taxes payable
1,568
2,832
Customer deposits
30,396
28,201
Provisions
14,129
16,485
Derivative liabilities
26
299
Current portion of long-term lease liabilities
1,607
1,298
Current portion of long-term debt
24,431
8,177
160,387
136,960
Non-current liabilities
Long-term lease liabilities
11,036
9,458
Long-term debt
4,346
21,719
Income taxes payable
2,325
933
Deferred income taxes
3,462
3,966
Customer deposits
35,082
27,937
Provisions
74,058
70,924
Other liabilities
5,438
5,125
135,747
140,062
Total liabilities
296,134
277,022
Total equity
183,259
200,835
Total liabilities and equity
479,393
477,857
Advertisement 14
This advertisement has not loaded yet, but your article continues below.
Article content
Consolidated Statements of Loss
(in thousands of U.S. dollars, excluding number of shares and per share amounts)
Three-month periods ended
Fiscal years ended
February 29,
February 28,
February 29,
February 28,
2024
2023
2024
2023
$
$
$
$
Sales
117,894
115,141
346,816
370,429
Cost of sales
79,510
75,196
253,609
257,964
Gross profit
38,384
39,945
93,207
112,465
Administration costs
33,121
80,841
98,744
156,759
Other expense (income)
(91
)
1,700
448
1,568
Operating profit (loss)
5,354
(42,596
)
(5,985
)
(45,862
)
Finance income
64
240
459
467
Finance costs
(2,419
)
(758
)
(6,805
)
(2,019
)
Finance costs – net
(2,355
)
(518
)
(6,346
)
(1,552
)
Income (loss) before income taxes
2,999
(43,114
)
(12,331
)
(47,414
)
Income tax expense
5,088
4,102
7,471
8,045
Net loss for the period
(2,089
)
(47,216
)
(19,802
)
(55,459
)
Net income (loss) attributable to:
Subordinate Voting Shares and Multiple Voting Shares
(2,083
)
(47,164
)
(19,737
)
(55,453
)
Non-controlling interest
(6
)
(52
)
(65
)
(6
)
Net loss for the period
(2,089
)
(47,216
)
(19,802
)
(55,459
)
Net loss per Subordinate and Multiple Voting Share
Basic and diluted
(0.09
)
(2.18
)
(0.91
)
(2.57
)
Dividends declared per Subordinate and Multiple
–
–
0.02
0.02
Voting Share
(CA$ –
)
(CA$ –
)
(CA$0.03
)
(CA$0.03
)
Total weighted average number of Subordinate and
Multiple Voting Shares
Basic and diluted
21,585,635
21,585,635
21,585,635
21,585,635
Advertisement 15
This advertisement has not loaded yet, but your article continues below.
Article content
Consolidated Statements of Comprehensive Loss
(in thousands of U.S. dollars)
Three-month periods ended
Fiscal years ended
February 29,
February 28,
February 29,
February 28,
2024
2023
2024
2023
$
$
$
$
Comprehensive loss
Net loss for the period
(2,089
)
(47,216
)
(19,802
)
(55,459
)
Other comprehensive income (loss)
Foreign currency translation
(719
)
1,423
2,516
(8,985
)
Comprehensive loss
(2,808
)
(45,793
)
(17,286
)
(64,444
)
Comprehensive income (loss) attributable to:
Subordinate Voting Shares and Multiple Voting Shares
(2,802
)
(45,741
)
(17,221
)
(64,438
)
Non-controlling interest
(6
)
(52
)
(65
)
(6
)
Comprehensive loss
(2,808
)
(45,793
)
(17,286
)
(64,444
)
Other comprehensive loss is composed solely of items that may be reclassified subsequently to the consolidated statement of loss.
Consolidated Statements of Changes in Equity
(in thousands of U.S. dollars, excluding number of shares)
Equity attributable to the Subordinate and Multiple Voting shareholders
Share capital
Contributed surplus
Accumulated other comprehensive loss
Retained earnings
Total
Non-controlling interest
Total equity
Balance – February 28, 2022
72,695
6,260
(32,126
)
217,995
264,824
686
265,510
Net loss for the year
–
–
–
(55,453
)
(55,453
)
(6
)
(55,459
)
Other comprehensive loss
–
–
(8,985
)
–
(8,985
)
–
(8,985
)
Comprehensive loss
–
–
(8,985
)
(55,453
)
(64,438
)
(6
)
(64,444
)
Acquisition of non-controlling interests
–
–
–
–
–
266
266
Other
–
–
(97
)
97
–
–
–
Dividends
Multiple Voting Shares
–
–
–
(366
)
(366
)
–
(366
)
Subordinate Voting Shares
–
–
–
(131
)
(131
)
–
(131
)
Balance – February 28, 2023
72,695
6,260
(41,208
)
162,142
199,889
946
200,835
Net loss for the year
–
–
–
(19,737
)
(19,737
)
(65
)
(19,802
)
Other comprehensive loss
–
–
2,516
–
2,516
–
2,516
Comprehensive loss
–
–
2,516
(19,737
)
(17,221
)
(65
)
(17,286
)
Acquisition of non-controlling interests
–
–
–
–
–
201
201
Dividends
Multiple Voting Shares
–
–
–
(354
)
(354
)
–
(354
)
Subordinate Voting Shares
–
–
–
(137
)
(137
)
–
(137
)
Non-controlling interest
–
–
–
–
–
–
–
Balance – February 29, 2024
72,695
6,260
(38,692
)
141,914
182,177
1,082
183,259
Advertisement 16
This advertisement has not loaded yet, but your article continues below.
Article content
Consolidated Statements of Cash Flow
(in thousands of U.S. dollars)
Three-month periods ended
Fiscal years ended
February 29,
February 28,
February 29,
February 28,
2024
2023
2024
2023
$
$
$
$
Cash flows from
Operating activities
Net loss for the period
(2,089
)
(47,216
)
(19,802
)
(55,459
)
Adjustments to reconcile net loss to cash provided by operating activities
12,669
64,794
14,289
67,553
Changes in non-cash working capital items
9,069
911
9,814
(11,572
)
Cash provided by operating activities
19,649
18,489
4,301
522
Investing activities
Short-term investments
(5,254
)
9,367
(5,232
)
8,250
Additions to property, plant and equipment
(2,925
)
(1,385
)
(6,829
)
(4,370
)
Additions to intangible assets
(1,199
)
(903
)
(2,358
)
(2,219
)
Proceeds on disposal of property, plant and equipment
(127
)
141
(45
)
185
Net change in other assets
317
(117
)
347
(87
)
Cash provided (used) by investing activities
(9,198
)
7,103
(14,127
)
1,759
Financing activities
Dividends paid to Subordinate and Multiple Voting shareholders